ACTRN12623000458639
Recruiting
N/A
The New predictiVe factors that drIve coronary atheroscleroSIs follOwiNg Coronary Artery Disease (VISION-CAD)” study
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Coronary artery disease
- Sponsor
- South Australian Health and Medical Research Institute
- Enrollment
- 300
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects who have received a clinically indicated coronary angiogram for stable or unstable CAD, including stable angina, unstable angina and acute myocardial infarction (MI), comprising non\-ST elevation MI (NSTEMI) or ST\-elevation MI (STEMI).
- •All subjects will be managed as per their treating clinicians, including with percutaneous coronary intervention (PCI) where indicated and use of antiplatelets, lipid\-lowering medication (e.g. statins) and other guideline\-recommended therapies.
- •Eligible subjects will be those who at the time of angiography are identified as having at least one major coronary artery system (left main, left anterior descending, left circumflex, ramus intermedius or right coronary artery) that will be left with residual coronary plaque with no intention to revascularise this by PCI or bypass grafting for at least the next 12 months. Age 18 years or more at the time of screening.
- •Able to provide informed consent to undergo non\-invasive CTCA imaging within 30 days of their index angiogram and return for a follow\-up CTCA 12±1 months later.
- •Willingness to provide a blood sample (50 mL) around the time of their baseline and follow\-up CTCA, and attend for an additional face\-to\-face study visit or receive a phone call at 6 months.
Exclusion Criteria
- •Any associated co\-morbidity in which the life expectancy is \<1 year.
- •Dialysis or estimated glomerular filtration rate (eGFR) \<30 ml/min/1\.73m2
- •Previous or planned coronary artery bypass grafting
- •Active malignancy with ongoing or planned chemotherapy or radiation therapy
- •Contraindications to CTCA
- •Women of childbearing potential who are not partaking in contraception
- •Unable to give informed consent
- •Not willing or able to attend follow\-up visits/repeat CTCA in 12 months
- •Concurrent enrollment in a placebo\-controlled trial or within 30 days of finishing a trial
- •Any other information that the investigators consider will limit the ability of the participant to complete all study associated procedures and visits
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Identification of risk factors for acute coronary events by Optical Coherence Tomography after STEMI and NSTEMI in patients with residual non-flow limiting lesions: the PECTUS-obs Trial (observational cohort)Atherosclerosisvulnerable plaque1001108210003216NL-OMON48078Radboud Universitair Medisch Centrum329
Completed
N/A
Connection of cardiac risk factors with cardiac vessel blood flow pattern after emergency coronary angioplastyHealth Condition 1: I219- Acute myocardial infarction, unspecifiedCTRI/2022/07/044226Department of Cardiology240
Completed
N/A
Personalized Risk Prediction in Coronary Artery DiseaseCoronary artery diseaseI25Chronic ischaemic heart diseaseDRKS00020960Deutsches Herzzentrum München der Technischen Universität1,400
Not Yet Recruiting
N/A
Identification of Genetic and Hereditary factors affecting young adults with cardiac diseases.CTRI/2015/12/006467Medanta The Medicity1,000
Completed
N/A
Study of the Effect of Diabetes on the Incidence and the Extent of Coronary Artery DiseasePatients Undergoing Coronary AngiographyNCT01585948University of Ioannina1,104